METROPOLIS - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.7

📉 Optimal Entry Price: ₹1,990–₹2,010 (near 50 DMA and RSI support)

📈 Exit Strategy (if holding): ₹2,250–₹2,260 (near recent high and resistance)

🔷 Positive

• 📊 Quarterly PAT growth of 13.8%: From ₹23.8 Cr. to ₹35.6 Cr., showing earnings momentum.
• 📈 ROCE (13.4%) and ROE (10.5%): Reflect decent capital efficiency.
• 📈 Trading above DMA 50 and 200: Indicates technical strength and trend continuation.
• 📈 DII holding increased by 0.70%: Signals rising domestic institutional confidence.
• 📊 Volume above 1-week average: Suggests growing interest and liquidity.

⚠️ Limitation

• 📉 High P/E of 81.4: Significantly above industry average (43.2), indicating overvaluation.
• 📉 PEG ratio of -5.83: Reflects poor valuation relative to growth.
• 📉 MACD at -14.7: Indicates bearish momentum.
• 📉 Dividend yield of 0.00%: Not attractive for income-focused investors.
• 📉 FII holding dropped by 0.31%: Reflects cautious foreign sentiment.

📉 Company Negative News

• 📉 Analysts flagged valuation concerns due to high P/E and slowing margin expansion.
• 📉 TruHealth segment growth may face seasonal moderation post festive demand.

📈 Company Positive News

• 📈 Q2FY26 net profit rose 13% YoY to ₹53 Cr., driven by higher patient and test volumes.
• 📊 EBITDA grew 20.5% YoY to ₹108.6 Cr., supported by wellness and specialty testing segments.
• 📈 Revenue increased 22.7% YoY to ₹429 Cr., reflecting strong operational performance.

🧬 Industry

• 🏥 Operates in the diagnostics and healthcare services sector, which benefits from rising preventive care demand.
• 📈 Industry P/E of 43.2 suggests Metropolis trades at a premium, likely due to brand strength and urban presence.

🧾 Conclusion

• ⚠️ Metropolis is a cautious swing trade candidate with strong fundamentals but valuation and technical headwinds.
• 📌 Entry near ₹1,990–₹2,010 offers a low-risk setup if RSI stabilizes and MACD reverses.
• 🚪 If already holding, consider exiting near ₹2,250–₹2,260, aligning with resistance and recent highs.

I can also compare Metropolis with Dr. Lal PathLabs or Thyrocare to help refine your swing strategy.